Key statistics
On Friday, Design Therapeutics Inc (DSGN:NSQ) closed at 5.88, -14.91% below its 52-week high of 6.91, set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.82 |
---|---|
High | 6.13 |
Low | 5.77 |
Bid | 5.39 |
Offer | 6.15 |
Previous close | 5.86 |
Average volume | 726.37k |
---|---|
Shares outstanding | 56.62m |
Free float | 35.98m |
P/E (TTM) | -- |
Market cap | 332.93m USD |
EPS (TTM) | -0.8982 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
- Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
- Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
- Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
- Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
- Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
- Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
More ▼